New guidance clarifying which pharmaceutical products will be exempt from recently imposed 100% import tariffs has been issued by the US Department of Commerce. The move creates carve-outs for certain specialty medicines and establishes pathways for additional relief.
The guidance, issued by the Commerce Department’s Bureau of Industry and Security following